From: PIK3CAmutation impact on survival in breast cancer patients and in ERα, PR and ERBB2-based subgroups
Exon | Nucleotide | Codon | Number of mutations |
---|---|---|---|
9 | c.1634A > C | Glu545Ala | 2 |
9 | c.1636C > A | Gln546Lys | 2 |
9 | c.1624 G > A | Glu542Lys | 20 |
9 | c.1634A > G | Glu545Gly | 1 |
9 | c.1633 G > A | Glu545Lys | 32 |
9 | c.1633 G > C | Glu545Gln | 1 |
9 | c.1490A > G | Asn497Ser | 1 |
9 | c.1636C > A | Gln546Lys | 2 |
9 | c.1637A > C | Gln546Pro | 1 |
9 | c.1637A > G | Gln546Arg | 2 |
20 | c.3203dupA | Asn1068Lys | 2 |
20 | c.3140A > T | His1047Leu | 8 |
20 | c.3140A > G | His1047Arg | 70 |
20 | c.3132T > A | Asn1044Lys | 1 |
20 | c.3145 G > C | Gly1049Arg | 2 |
20 | c.3155C > A | Thr1052Lys | 1 |
20 | c.[3085 > C(+)3140A > T] | p.[Asp1029His(+)His1047Leu] | 1 |
20 | c.[3140A > T(+)3197C > T] | p.[His1047Leu(+)Ala1066Val] | 1 |
9+20 | c.[1624 G < A(+)3127A > G] | p.[Glu542Lys(+)Met1043Val] | 1 |
Total = 151 |